Week In Review: WuXi PharmaTech To List Subsidiary On China’

Deals and Financings WuXi PharmaTech (NYSE: WX), China’s largest CRO/CMO, has filed to list its chemical manufacturing subsidiary, SynTheAll Pharmaceutical Co. Ltd., on China’s Third Board, a two-year old electronic OTC exchange (see story). Although it has submitted a listing application, WuXi said it may not conduct an IPO for STA immediately after approval. WuXi further explained…

Data Still Makes Case For Stocks

“Davidson” submits: Economic data speaks volumes! It indicates that investors should weather any volatility till the data tells us that the economy is peaking. Investors should not pull the trigger on portfolios ‘til’ we see the whites of their eyes’. The BLS Job Openings data in the chart below indicates that we remain at a…

The Expanding Uses Of Gold

Last week, Peter Schiff defended the intrinsic value of gold by briefly explaining how many uses it has beyond bullion investment. Many people have no idea how integral gold is to products they rely upon every day, not to mention exciting technologies of the future. People who argue that gold is becoming less useful in…

Instant Coffee Prices Rising Fast

All year long, I’ve reported on the upward price movement of Arabica coffee beans, the high-quality beans used in gourmet coffees, like what you would find at your local Starbucks (SBUX). A drought in Brazil adversely affected this year’s coffee crop. The current weather may also affect next year’s crop, too, as this is a critical flowering…

Deflation

Well, now that the title has hopefully gotten your attention I’d like to talk about the ‘d’ and ‘i’ words that so many financial types – myself included – throw around so often.  This is due to a reader/subscriber KR’s aggravation at my use of the word deflation, which he had thought was meant sarcastically,…